About WORK Medical Technology Group Ltd.
https://www.hzsy120.comWORK Medical Technology Group LTD, together with its subsidiaries, manufactures and sells medical consumables in the People's Republic of China and internationally.
CEO
Shuang Wu
Compensation Summary
(Year )
Total Compensation (Unknown At The Moment)
Industry Medical - Instruments & Supplies
Sector Healthcare
Went public August 23, 2024
Method of going public SPAC
Full time employees 216
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2025-12-29 | Reverse | 1:100 |
| 2025-10-21 | Reverse | 1:100 |
Ratings Snapshot
Rating : D+
Discounted Cash Flow 1
Return On Equity 1
Return On Assets 1
Debt To Equity 1
Price To Earnings 1
Price To Book 1
Overall Score 1
Price Target
Target High $0
Target Low $0
Target Median $0
Target Consensus $0
Institutional Ownership
SABBY MANAGEMENT, LLC
Shares:2.72M
Value:$7M
VIRTU FINANCIAL LLC
Shares:311.82K
Value:$801.38K
FEDERATION DES CAISSES DESJARDINS DU QUEBEC
Shares:200K
Value:$514K
Summary
% Of Shares Owned 58611.07%
Total Number Of Holders 9
Showing Top 3 of 9
Market Cap $13452
52w High $60000.00
52w Low $1.85
P/E 0
Volume 4.04M
Outstanding Shares 5.70K
About WORK Medical Technology Group Ltd.
https://www.hzsy120.comWORK Medical Technology Group LTD, together with its subsidiaries, manufactures and sells medical consumables in the People's Republic of China and internationally.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2025 | $4.54M ▼ | $3.13M ▼ | $13.16K ▲ | 0.29% ▲ | $0.1 ▲ | $-1.23M ▲ |
| Q4-2024 | $6.2M ▲ | $4.86M ▲ | $-3.72M ▼ | -60.01% ▼ | $-28 ▼ | $-2.85M ▼ |
| Q2-2024 | $5.31M ▲ | $2.05M ▲ | $226.53K ▲ | 4.27% ▲ | $1.82 ▲ | $200.61K ▲ |
| Q4-2023 | $4.55M ▼ | $1.76M ▼ | $-1.36M ▼ | -29.94% ▼ | $-10.9 ▼ | $-625.55K ▼ |
| Q2-2023 | $9.01M | $1.89M | $1.48M | 16.38% | $11.67 | $2.71M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2025 | $2M ▼ | $34.71M ▼ | $19M ▼ | $12.95M ▼ |
| Q4-2024 | $6.56M ▲ | $36.25M ▲ | $20.18M ▼ | $13.19M ▲ |
| Q2-2024 | $1.04M ▼ | $32.49M ▲ | $21.16M ▲ | $10.21M ▲ |
| Q4-2023 | $1.6M | $29.96M | $18.97M | $9.88M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2025 | $13.16K ▲ | $-5.59M ▼ | $3.53M ▲ | $-7.05M ▼ | $2.4M ▲ | $-3.04M ▲ |
| Q4-2024 | $-3.72M ▼ | $-963.4K ▲ | $-3.21M ▲ | $9.1M ▲ | $-1.08M ▼ | $-10.16M ▼ |
| Q2-2024 | $226.53K ▲ | $-1.26M ▼ | $-5.86M ▼ | $6.56M ▲ | $0 | $-1.29M ▼ |
| Q4-2023 | $-1.36M ▼ | $1.49M ▲ | $-60.82K ▲ | $-641.61K ▼ | $0 ▼ | $1.57M ▲ |
| Q2-2023 | $1.43M | $719.46K | $-522.49K | $-87.11K | $863.86K | $52.92K |
CEO
Shuang Wu
Compensation Summary
(Year )
Total Compensation (Unknown At The Moment)
Industry Medical - Instruments & Supplies
Sector Healthcare
Went public August 23, 2024
Method of going public SPAC
Full time employees 216
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2025-12-29 | Reverse | 1:100 |
| 2025-10-21 | Reverse | 1:100 |
Ratings Snapshot
Rating : D+
Discounted Cash Flow 1
Return On Equity 1
Return On Assets 1
Debt To Equity 1
Price To Earnings 1
Price To Book 1
Overall Score 1
Price Target
Target High $0
Target Low $0
Target Median $0
Target Consensus $0
Institutional Ownership
SABBY MANAGEMENT, LLC
Shares:2.72M
Value:$7M
VIRTU FINANCIAL LLC
Shares:311.82K
Value:$801.38K
FEDERATION DES CAISSES DESJARDINS DU QUEBEC
Shares:200K
Value:$514K
Summary
% Of Shares Owned 58611.07%
Total Number Of Holders 9
Showing Top 3 of 9